Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q4 | Feb 18, 2026 | Harvest Lane Asset Management | 3.3% | 9.1% | ASK.AX, AUB.AX, BBT.AX, DSE.AX, MYX.AX, NWC.AX, PBH.AX, PEK.AX, SLH.AX, STO.AX, WA8.AX, XAM.AX, XF1.AX | Absolute return, activism, Australia, Merger Arbitrage, special situations, takeovers | The fund participated in merger arbitrage opportunities across multiple sectors, with notable activity in pharmaceutical deals including Mayne Pharma Group Limited where the bidder attempted to walk from the deal. The fund was publicly outspoken about Cosette Pharmaceuticals acting in bad faith when trying to exit their acquisition of Mayne Pharma. May saw three deals in the copper space within a week, with the fund thinking at least one was ripe for a contest. New World Resources Limited saw significant action with multiple bidders, starting as a friendly scheme and ultimately seeing nine bids total with Kinterra Capital emerging as the victor. | MYX AU XF1 AU STO AU |
View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| No pitches found. | |||||||||
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||